Ontology highlight
ABSTRACT:
SUBMITTER: Brinson RG
PROVIDER: S-EPMC6057790 | biostudies-literature | 2017 Jul
REPOSITORIES: biostudies-literature
Brinson Robert G RG Ghasriani Houman H Hodgson Derek J DJ Adams Kristie M KM McEwen Ian I Freedberg Darón I DI Chen Kang K Keire David A DA Aubin Yves Y Marino John P JP
Journal of pharmaceutical and biomedical analysis 20170404
The higher order structure (HOS) of biotherapeutics is a critical quality attribute that can be evaluated by nuclear magnetic resonance (NMR) spectroscopy at atomic resolution. NMR spectral mapping of HOS can be used to establish HOS consistency of a biologic across manufacturing changes or to compare a biosimilar to an innovator reference product. A previous inter-laboratory study performed using filgrastim drug products demonstrated that two-dimensional (2D)-NMR <sup>1</sup>H<sup>N</sup>-<sup> ...[more]